Annals of internal medicine
Risk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists : A Systematic Review and Meta-analysis.
Albert Ko, Yu-Cheng Chang, Furkan Bahar, Tsu Hsien Wang, Nutchapon Xanthavanij, Chun-Chiao Yu, Rebecca Jen-Ling Hsieh, Xin Ya See, Shao-Wei Lo, Junmin Song, Yuan Ping Hsia, Cho-Hung Chiang, Xiaocao Xu, Shuwen Lin, Cho-Han Chiang
Published: 202510.7326/ANNALS-25-02237
Abstract
BACKGROUND: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are used for type 2 diabetes mellitus (T2DM) and overweight or obesity, but their association with cancer is unclear. PURPOSE: To investigate the risk for obesity-related cancer associa…
Preview only. Read the full abstract at the source